![Use of novel, non-imidazole inverse agonist radioligands to define histamine H3receptor pharmacology]()
Use of novel, non-imidazole inverse agonist radioligands to define histamine H3receptor pharmacologyT. A. Esbenshade; B. B. Yao; D. G. Witte; T. L. Carr; R. Sharma; J. L. Baranowski; K. M. Krueger; T. R. Miller; B. W. Surber; R. Faghih; A. A. Hancock · 2005